Mechanistic analysis shows that miR-375 is significantly downregulated in CRC, which enhances drug resistance and cell proliferation and inhibits apoptosis by releasing YAP1 and SP1, and the activation of the Hippo-YAP1 pathway upregulates YAP1 expression. Here, SP1 is linked to colorectal carcinoma.